Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands,
Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
Dermatology. 2024;240(2):282-290. doi: 10.1159/000535510. Epub 2023 Nov 27.
Skin cancer is currently the most common cancer type worldwide, and numbers are rapidly increasing. To improve primary prevention, individualised prevention strategies may be of interest as this enhances the chance of long-term behavioural change. The Sun Exposure and Protection Index (SEPI), previously validated in multiple languages, is a tool that could help identify individuals with risky behaviour and tailor interventions to the person's propensity to change. The aim of the present study was to investigate the reliability and validity of a Dutch version of the SEPI for both usage in daily clinical practice and research.
Patients were included at primary care settings and dermatology outpatient settings in a 1:1 ratio. Participants were asked to fill out the SEPI together with some baseline characteristics and the previously validated FACE-Q Skin Cancer - Sun Protection module. Construct validity was tested by comparing SEPI part I and the FACE-Q module using Spearman's Rho. Internal consistency was assessed with Cronbach's Alpha for both SEPI parts separately. To assess test-retest reliability, the SEPI was again filled out 3 weeks later, and scores were compared with Cohen's weighted Kappa.
Of the 171 participants completing the first questionnaire, 147 (86.0%) participants also completed the follow-up questionnaire. Comparison between the corresponding SEPI part I and FACE-Q module questions showed good correlations regarding sun exposure habits (correlation coefficients ranging from 0.61 to 0.85). Internal consistency of SEPI part I was 0.63 and SEPI part II was 0.65. The test-retest analysis indicated reproducibility over time (weighted Kappa ranging from 0.38 to 0.76).
In conclusion, the Dutch version of the SEPI is shown to be a valid and reliable tool for both usages in daily clinical practice and research to evaluate individual ultraviolet exposure and measure a person's propensity to limit it.
皮肤癌是目前全球最常见的癌症类型，且发病率正在迅速上升。为了改善初级预防，个体化预防策略可能会引起关注，因为这增加了长期行为改变的机会。Sun Exposure and Protection Index（SEPI），之前已在多种语言中得到验证，是一种可以帮助识别有风险行为的个体并根据个人改变的倾向来调整干预措施的工具。本研究的目的是调查 SEPI 的荷兰语版本在日常临床实践和研究中的可靠性和有效性。
在初级保健机构和皮肤科门诊以 1:1 的比例纳入患者。要求参与者填写 SEPI 以及一些基线特征和之前经过验证的 FACE-Q 皮肤癌-防晒模块。通过 Spearman's Rho 比较 SEPI 第一部分和 FACE-Q 模块来测试结构有效性。使用 Cronbach's Alpha 分别评估 SEPI 两部分的内部一致性。为了评估测试-重测信度，3 周后再次填写 SEPI，并使用 Cohen 的加权 Kappa 比较分数。
在完成第一份问卷的 171 名参与者中，有 147 名（86.0%）参与者还完成了随访问卷。SEPI 第一部分和对应的 FACE-Q 模块问题之间的比较显示出良好的相关性，涉及阳光暴露习惯（相关系数范围为 0.61 至 0.85）。SEPI 第一部分的内部一致性为 0.63，SEPI 第二部分为 0.65。测试-重测分析表明随着时间的推移具有可重复性（加权 Kappa 范围为 0.38 至 0.76）。
总之，SEPI 的荷兰语版本被证明是一种有效且可靠的工具，可用于日常临床实践和研究中评估个体紫外线暴露并衡量个人限制紫外线暴露的倾向。
Zotero 插件